Uncategorized
Santen Receives FDA Approval for Verkazia™ (Cyclosporine Ophthalmic Emulsion) 0.1% for the Treatment of Vernal Keratoconjunctivitis in Children and Adults
EMERYVILLE, Calif.--(BUSINESS WIRE)--The U.S. FDA has approved Santen's Verkazia™ (cyclosporine ophthalmic emulsion) 0.1% eye drops for the treatment of VKC in children and adults.